Onkologie. 2008:2(4):234-238

CENTRAL NERVOUS SYSTEM TUMORS IN CHILDREN AND ADOLESCENTS

Markéta Chráčková
Klinika dětské hematologie a onkologie, UK 2. LF a FN Motol, Praha

Brain tumors are the most prevalent types of pediatric solid cancer. The prognosis of the patients is still unfavorable. The progress in molecular biology and genetics in the last years designates additional biologic markers and prognostic factors and can facilitate individual treatment. With the collaboration in international expert groups and with using the new treatment modalities and international therapeutical protocols we can increase the chance for survival of patients.

Keywords: Key words: tumor, central nervous system, treatment, prognosis.

Published: December 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chráčková M. CENTRAL NERVOUS SYSTEM TUMORS IN CHILDREN AND ADOLESCENTS. Onkologie. 2008;2(4):234-238.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Albright AL a kol. Effects of medulloblastoma resections on outcome in children: A report from the Children's Cancer Group, Neurosurgery, sv. 38, 1996; 265 s. Go to original source... Go to PubMed...
    2. Bělohlávek O, Jarůšková M, Šimonová K, Kantorová I. Atlas of positron emission tomography. Praha 2003.
    3. Hughes EN a kol. Medulloblastoma at the Joint Center for Radiation Therapy between 1968 and 1984, Cancer, sv. 61 s. 1992, 1988. Go to original source...
    4. Koutecký J a spol. Nádorová onemocnění dětí a mladistvých. Praha: Karolinum 1997.
    5. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO Classification of Tumors of the Central Nervous System. Acta Neuropathologica 2007; 114: 97-109. Go to original source... Go to PubMed...
    6. Morris EB, Gajjar A, Okuma JO, et al. Survival and late mortality in long-term survivors of pediatric CNS tumors. Journal of Clinical Oncology 2007; 25(12): 1532-1538. Go to original source... Go to PubMed...
    7. Pizzo PA & Poplack DG (Eds.). Principles and practice of pediatric oncology 4th Ed. Philadelphia: Lippincott Williams & Wilkins.
    8. Scheurlen, Schwabe, Joos, Mollenhauer, Sorensen, Kuhl: Molecular Analysis of Childhood Primitive Neuroectodermal Tumors Defines Markers Associated With Poor Outcome. J. Clin. Oncol. 1998; 16: 2478-2485. Go to original source... Go to PubMed...
    9. Strother D, Ashley D, Kellie SJ, et al. Feasibility of Four Consecutive High-Dose Chemotherapy Cycles With Stem-Cell Rescue for Patients With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor After Craniospinal Radiotherapy: Results of a Collaborative Study. Journal of Clinical Oncology 2001; 19(10): 2696-2704. Go to original source... Go to PubMed...
    10. Van der Hiel B, Pauwels EKJ, Stokkel MP M. Positron emission tomography with 2-[18F]-fluoro-2.deoxy-D-glucose in oncology. J Cancer Res Clin Oncol 2001; 127: 269-277. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.